Skip to main navigation Skip to search Skip to main content
Dimitrios Lamprou

View Scopus Profile

Dimitrios Lamprou

Professor

 https://orcid.org/0000-0002-8740-1661

  • Room 01.060 - Pharmacy & MCI

    United Kingdom

Accepting PhD Students

PhD projects

The Lamprou Laboratory welcomes outstanding PhD candidates interested in Advanced Drug Delivery, Biofabrication, Microfluidics, Nanomedicine, AI-Enabled Pharmaceutical Technologies, and Precision Medicine. Candidates should have a strong academic background and ideally a secured funding pathway. Please contact Professor Lamprou with a CV and a brief (1-page) research statement.

20082026

Research activity per year

Personal profile

Particulars

Professor Dimitrios A. Lamprou (PhD, MBA) is Chair of Biofabrication and Advanced Manufacturing in the School of Pharmacy at Queen's University Belfast and serves as Director of Internationalisation.

His research focuses on Advanced Pharmaceutical Manufacturing and Drug Delivery Technologies for Personalised Healthcare.

Professor Dimitrios Lamprou is an internationally recognised researcher in Intelligent Pharmaceutical Technologies. His work integrates advanced drug delivery, biofabrication, microfluidics, artificial intelligence and pharmaceutical manufacturing to create next-generation medicines and healthcare solutions.

His interdisciplinary research bridges pharmaceutical science, engineering and medicine to develop advanced pharmaceutical manufacturing platforms, next-generation drug delivery systems and translational healthcare technologies. Working closely with academic institutions, healthcare organisations and industry partners worldwide, he supports the translation of emerging technologies into real-world clinical, societal and industrial impact.

Professor Lamprou welcomes opportunities to participate in national and international research consortia, including Horizon Europe, ERC, UKRI, NIHR, Innovate UK and industry-funded programmes. Through international partnerships and interdisciplinary collaboration, he aims to advance intelligent pharmaceutical technologies that improve patient outcomes, healthcare sustainability and global health.

Successfully advanced the School's and faculty internationalisation agenda through the development of strategic partnerships, global engagement activities, and international networks. This work has enhanced institutional visibility, created opportunities for research and education collaboration, supported transnational initiatives, and strengthened the University's international footprint.

Achievements

  • Published 180+ peer-reviewed journal articles and book chapters, and more than 500 conference abstracts, contributing to advances in pharmaceutical science, engineering and healthcare technologies.
  • Secured more than £6 million research funding from UK and international funding bodies, charities and industry.
  • Developed and led strategic international partnerships and collaborative research networks spanning Europe, North America, Asia and the Middle East, supporting joint research, capacity building, academic mobility and transnational education initiatives.
  • Delivered 230+ invited keynote, plenary and distinguished lectures at international conferences and scientific meetings.
  • Supervised and mentored undergraduate, postgraduate and doctoral researchers across pharmaceutical, biomedical and engineering disciplines.
  • Contributed to the translation of innovative pharmaceutical technologies through industrial engagement, interdisciplinary collaboration and international partnerships.
  • Recognised internationally for contributions to advanced drug delivery, intelligent pharmaceutical technologies, microfluidics, biofabrication and pharmaceutical engineering.
  • Led research programmes advancing personalised medicine, AI-enabled pharmaceutical innovation and sustainable healthcare technologies.
Through multidisciplinary research, international partnerships and industrial collaboration, Professor Lamprou has established a globally connected research programme focused on advancing intelligent pharmaceutical technologies, advanced therapeutics and sustainable healthcare innovation. His work combines pharmaceutical science, engineering, artificial intelligence and medicine to develop next-generation solutions that improve patient outcomes, support industrial innovation and address emerging global healthcare challenges.

Other

Strategic Contributions & Engagement

  • Extensive involvement in international academic collaborations, research networks and multi-institutional consortia, supporting global research and capacity-building initiatives.
  • Strong engagement with industry partners, healthcare organisations and translational research programmes, facilitating the development and implementation of innovative healthcare technologies.
  • Leadership of interdisciplinary research activities spanning pharmaceutical sciences, engineering, medicine and digital technologies, promoting cross-sector collaboration and innovation.
  • Active contribution to institutional, national and international committees, professional organisations, peer-review panels and strategic initiatives that support research excellence and international engagement.
  • Through his roles as Chair of Biofabrication & Advanced Manufacturing and Director of Internationalisation, Professor Lamprou supports the development of international partnerships, research collaboration, academic mobility, capacity building and strategic initiatives that enhance institutional visibility, research growth and global impact.
  • Leads strategic internationalisation initiatives that strengthen global academic partnerships, research collaboration networks, international student pathways and transnational education opportunities.
Through academic leadership, multidisciplinary research and international collaboration, Professor Lamprou has established a globally connected research and innovation programme focused on advanced drug delivery, intelligent pharmaceutical technologies and sustainable healthcare solutions. His work contributes to research excellence, capacity building and the translation of emerging technologies into clinical, industrial and societal impact.

Research Focus

Our Research
The Lamprou Laboratory develops next-generation medicines and healthcare technologies through the integration of pharmaceutical science, engineering, and advanced manufacturing. Our research is organised around three interconnected pillars that span the design, manufacture, and translation of innovative therapeutic systems.
 
Pillar 1: Advanced Pharmaceutical Manufacturing
We develop the technologies and processes needed to manufacture the medicines of the future. This research includes additive manufacturing (3D printing), hot-melt extrusion (HME), electrospinning, digital manufacturing, artificial intelligence (AI), and process innovation for personalised and scalable pharmaceutical production.
 
Pillar 2: Drug Delivery & Therapeutics
We design advanced therapeutic systems that improve how medicines are delivered to patients. Our work focuses on microneedles, implantable drug delivery systems, nanoparticles, biologics, and long-acting formulations that enhance efficacy, safety, and patient adherence.
 
Pillar 3: Biofabrication & Translational Technologies
We develop enabling technologies that bridge discovery and clinical translation. This includes microfluidics, organ-on-chip platforms, biomaterials, regenerative systems, and next-generation experimental models for precision medicine and healthcare innovation.
 
Our Vision
By combining advanced manufacturing, drug delivery, and biofabrication, we aim to accelerate the development of personalised, sustainable, and clinically impactful healthcare solutions that improve patient outcomes worldwide.
 
Interdisciplinary Research
Our interdisciplinary research programme integrates pharmaceutical science, engineering, artificial intelligence and medicine to address major healthcare challenges through advanced therapeutics, intelligent manufacturing, regenerative technologies and precision medicine. We work closely with academic, clinical and industrial partners to accelerate translation from discovery to real-world healthcare and societal impact while promoting sustainable and environmentally responsible innovation.

Teaching

Teaching & Research Environment

Professor Lamprou contributes to undergraduate and postgraduate education across a wide range of pharmaceutical sciences, pharmaceutical engineering, biotechnology and healthcare innovation disciplines. His teaching integrates cutting-edge research, industrial relevance and real-world application, preparing students for careers in academia, healthcare, industry and entrepreneurship.

Teaching leadership includes the development and delivery of postgraduate programmes aligned with emerging technologies, industry needs and future workforce demands, supporting the education of highly skilled graduates and the training of future research leaders.

He has played a key role in shaping research-led postgraduate education and interdisciplinary training environments, fostering innovation, critical thinking and international perspectives across pharmaceutical and biomedical sciences.

Professor Lamprou actively supervises undergraduate, MSc and PhD research projects and is committed to developing research-informed, industry-engaged and globally connected curricula that reflect developments in advanced drug delivery, intelligent pharmaceutical technologies, artificial intelligence, microfluidics, biofabrication and sustainable healthcare innovation.

Through the integration of education, research and professional practice, his teaching activities support the development of industry-ready, innovation-focused and research-oriented professionals equipped to address current and future challenges in pharmaceutical sciences and healthcare technologies.

Through the integration of research excellence, international collaboration and innovation-led education, Professor Lamprou contributes to the development of the next generation of scientists, innovators and academic leaders.

Other

Professional & Strategic Activities

  • Chair, UK & Ireland Controlled Release Society.
  • Co-Chair, EPSRC Bio-Effective Surface Treatment Network.
  • Member, British Standards Institution (BSI) AMT/8 Committee (Additive Manufacturing).
  • Section Editor-in-Chief, Pharmaceutics.
  • Contributor to national and international research, innovation and policy initiatives.
  • Engagement in advisory, evaluation, peer-review and research leadership activities.
  • Active participation in public engagement, knowledge exchange and professional outreach activities.
These roles support research leadership, international collaboration, policy engagement and the advancement of emerging technologies across pharmaceutical sciences, healthcare innovation and advanced manufacturing.

Industry, International & EDI Engagement

  • Active collaboration with academic partners, healthcare organisations, clinical networks and industry stakeholders.
  • Leadership of international research partnerships, global engagement initiatives and collaborative funding activities.
  • Commitment to equity, diversity and inclusion (EDI) in research, education and training environments.
  • Development of multidisciplinary, multicultural and internationally connected research teams.
  • Promotion of cross-sector, cross-border and interdisciplinary collaboration that supports research excellence and innovation.

As Director of Internationalisation, Professor Lamprou leads strategic initiatives that strengthen global partnerships, international research collaboration, academic mobility, student recruitment and transnational educational activities, enhancing both institutional visibility and international impact. Works with universities, healthcare organisations, policymakers and industry partners across Europe, Asia, the Middle East and North America to develop sustainable research, innovation and educational partnerships.

Academic Leadership & Global Engagement: Strategic leadership of internationalisation, partnership development, research capacity building, transnational education and interdisciplinary research initiatives that enhance institutional impact and global connectivity.

Current activities focus on accelerating technology translation, industry engagement, international collaboration and innovation partnerships, maximising the societal, healthcare and economic impact of research and educational activities.

Keywords

  • RS Pharmacy and materia medica
  • Biomaterials
  • Sustainable healthcare
  • Medical devices
  • Diagnostics
  • Pharmaceutical Innovation
  • Precision Therapeutics
  • RM Therapeutics. Pharmacology
  • Advanced Drug delivery
  • Nanomedicines
  • Regenerative medicine
  • Lipid Nanoparticles
  • Organ-on-Chip
  • Personalised Medicines
  • AI in Drug Development
  • Translational Pharmaceutics
  • Drug Product Design
  • TS Manufactures
  • Microfluidics
  • lab-on-a-chip
  • 3D Printing
  • 4D Printing
  • Pharmaceutical manufacturing
  • Electrospinning
  • Bioprinting
  • Hot-Melt Extrusion
  • Biofabrication
  • Advanced Manufacturing
  • Pharmaceutical Bioengineering
  • Digital Health Technologies
  • HD28 Management. Industrial Management
  • Digital Pharmaceutics
  • Pharmaceutical Management
  • Leadership

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  1. SDG 1 - No Poverty
    SDG 1 No Poverty
  2. SDG 2 - Zero Hunger
    SDG 2 Zero Hunger
  3. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  4. SDG 4 - Quality Education
    SDG 4 Quality Education
  5. SDG 5 - Gender Equality
    SDG 5 Gender Equality
  6. SDG 6 - Clean Water and Sanitation
    SDG 6 Clean Water and Sanitation
  7. SDG 8 - Decent Work and Economic Growth
    SDG 8 Decent Work and Economic Growth
  8. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure
  9. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities
  10. SDG 11 - Sustainable Cities and Communities
    SDG 11 Sustainable Cities and Communities
  11. SDG 12 - Responsible Consumption and Production
    SDG 12 Responsible Consumption and Production
  12. SDG 13 - Climate Action
    SDG 13 Climate Action
  13. SDG 15 - Life on Land
    SDG 15 Life on Land
  14. SDG 16 - Peace, Justice and Strong Institutions
    SDG 16 Peace, Justice and Strong Institutions
  15. SDG 17 - Partnerships for the Goals
    SDG 17 Partnerships for the Goals

Fingerprint

Dive into the research topics where Dimitrios Lamprou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles
View full fingerprint

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further
View all 10 projects
View all 216 research outputs
View all 18 prizes
View all 449 activities
View all 11 press/media